assessment of complex drug product – physicochemical characteristics to support in vitro be studies
Published 4 years ago • 1.5K plays • Length 19:32Download video MP4
Download video MP3
Similar videos
-
19:58
lab science to support generic complex drug product assessment
-
32:50
complex product characterization/analysis - session 2b
-
21:11
developing and implementing science-based standards in bioequivalence assessment
-
34:41
complex product characterization/analysis - session 2a
-
21:09
in vitro release testing for complex generics: a bioequivalence perspective
-
19:46
in vitro bioequivalence testing for topical ophthalmic suspension products (17of39) complex generics
-
20:45
in vitro bioequivalence studies of topical drug products: challenges and promises of ivrt and ivpt
-
0:56
us food and drug administration moves to ban red food dye
-
19:10
product-specific guidances for complex generic drugs
-
30:26
in vitro and in vivo abuse deterrence evaluation of generic opioids (30of39) complex generics 2018
-
1:57:52
complex generics: topical products, part 1
-
20:11
topical dosage forms: emerging insights and implications for bioequivalence approaches
-
1:16:01
in vitro and in vivo be approaches: challenges and opportunities – session 3b
-
10:42
multivesicular liposomes: physicochemical characterization & in vitro drug release testing (12of39)
-
20:46
in vitro studies for alternative be approaches to comparative clinical endpoint be studies
-
17:26
in vitro enteral (nasogastric and gastric) feeding tube testing of generic drugs: case studies
-
0:54
a new possible way to evaluate bioequivalence of topical drugs
-
14:52
postmarketing safety and surveillance of generic drugs update
-
22:22
model-informed and model-integrated approach in be assessment of long-acting injectable products